How to assess pharmacogenomic tests for implementation in the NHS in England

Sanghvi, Sonali, Ferner, Robin E, Scourfield, Andrew, Urquhart, Robert, Amin, Sejal, Hingorani, Aroon D and Sofat, Reecha
(2023) How to assess pharmacogenomic tests for implementation in the NHS in England. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 89 (9). pp. 2649-2657.

Access the full-text of this item by clicking on the Open Access link.


<h4>Aims</h4>Pharmacogenomic testing has the potential to target medicines more effectively towards those who will benefit and avoid use in individuals at risk of harm. Health economies are actively considering how pharmacogenomic tests can be integrated into health care systems to improve use of medicines. However, one of the barriers to effective implementation is evaluation of the evidence including clinical usefulness, cost-effectiveness, and operational requirements. We sought to develop a framework that could aid the implementation of pharmacogenomic testing. We take the view from the National Health Service (NHS) in England.<h4>Methods</h4>We used a literature review using EMBASE and Medline databases to identify prospective studies of pharmacogenomic testing, focusing on clinical outcomes and implementation of pharmacogenomics. Using this search, we identified key themes relating to the implementation of pharmacogenomic tests. We used a clinical advisory group with expertise in pharmacology, pharmacogenomics, formulary evaluation, and policy implementation to review data from our literature review and the interpretation of these data. With the clinical advisory group, we prioritized themes and developed a framework to evaluate proposals to implement pharmacogenomics tests.<h4>Results</h4>Themes that emerged from review of the literature and subsequent discussion were distilled into a 10-point checklist that is proposed as a tool to aid evidence-based implementation of pharmacogenomic testing into routine clinical care within the NHS.<h4>Conclusion</h4>Our 10-point checklist outlines a standardized approach that could be used to evaluate proposals to implement pharmacogenomic tests. We propose a national approach, taking the view of the NHS in England. Using this approach could centralize commissioning of appropriate pharmacogenomic tests, reduce inequity and duplication using regional approaches, and provide a robust and evidence-based framework for adoption. Such an approach could also be applied to other health systems.

Item Type: Article
Uncontrolled Keywords: health service, implementation, pharmacogenomics
Depositing User: Symplectic Admin
Date Deposited: 28 Jul 2023 13:56
Last Modified: 01 Sep 2023 10:15
DOI: 10.1111/bcp.15820
Open Access URL:
Related URLs: